Literature DB >> 10406732

Treating behavioural and psychological signs in Alzheimer's disease.

C Ballard, J O'Brien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10406732      PMCID： PMC1116255          DOI： 10.1136/bmj.319.7203.138

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up.

Authors:  R McShane; J Keene; K Gedling; C Fairburn; R Jacoby; T Hope
Journal:  BMJ       Date:  1997-01-25

2.  A prospective study of psychotic symptoms in dementia sufferers: psychosis in dementia.

Authors:  C Ballard; J O'Brien; B Coope; A Fairbairn; F Abid; G Wilcock
Journal:  Int Psychogeriatr       Date:  1997-03       Impact factor: 3.878

3.  Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia.

Authors:  E K Perry; E Marshall; J Kerwin; C J Smith; S Jabeen; A V Cheng; R H Perry
Journal:  J Neurochem       Date:  1990-10       Impact factor: 5.372

4.  Neuroleptic sensitivity in patients with senile dementia of Lewy body type.

Authors:  I McKeith; A Fairbairn; R Perry; P Thompson; E Perry
Journal:  BMJ       Date:  1992-09-19

5.  Neuropathological correlates of psychotic phenomena in confirmed Alzheimer's disease.

Authors:  H Förstl; A Burns; R Levy; N Cairns
Journal:  Br J Psychiatry       Date:  1994-07       Impact factor: 9.319

6.  A metaanalysis of controlled trials of neuroleptic treatment in dementia.

Authors:  L S Schneider; V E Pollock; S A Lyness
Journal:  J Am Geriatr Soc       Date:  1990-05       Impact factor: 5.562

7.  Presynaptic serotonergic dysfunction in patients with Alzheimer's disease.

Authors:  A M Palmer; P T Francis; J S Benton; N R Sims; D M Mann; D Neary; J S Snowden; D M Bowen
Journal:  J Neurochem       Date:  1987-01       Impact factor: 5.372
  7 in total
  9 in total

Review 1.  Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia.

Authors:  M E Hemels; K L Lanctôt; M Iskedjian; T R Einarson
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 2.  Agitation and Irritability in Alzheimer's Disease: Evidenced-Based Treatments and the Black-Box Warning.

Authors:  Aaron M Koenig; Steven E Arnold; Joel E Streim
Journal:  Curr Psychiatry Rep       Date:  2016-01       Impact factor: 5.285

Review 3.  Aromatherapy in the management of psychiatric disorders: clinical and neuropharmacological perspectives.

Authors:  Nicolette Perry; Elaine Perry
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial.

Authors:  Clive Ballard; Marisa Margallo-Lana; Edmund Juszczak; Simon Douglas; Alan Swann; Alan Thomas; John O'Brien; Anna Everratt; Stuart Sadler; Clare Maddison; Lesley Lee; Carol Bannister; Ruth Elvish; Robin Jacoby
Journal:  BMJ       Date:  2005-02-18

5.  Feasibility study of the BrightBrainer™ integrative cognitive rehabilitation system for elderly with dementia.

Authors:  Grigore Burdea; Kevin Polistico; Amalan Krishnamoorthy; Gregory House; Dario Rethage; Jasdeep Hundal; Frank Damiani; Simcha Pollack
Journal:  Disabil Rehabil Assist Technol       Date:  2014-03-29

Review 6.  Dementia with Lewy bodies: clinical features and treatment.

Authors:  S Campbell; S Stephens; C Ballard
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

7.  Relation between aerobic fitness and brain structures in amnestic mild cognitive impairment elderly.

Authors:  Camila Vieira Ligo Teixeira; Thiago J R Rezende; Marina Weiler; Mateus H Nogueira; Brunno M Campos; Luiz F L Pegoraro; Jessica E Vicentini; Gabriela Scriptore; Fernando Cendes; Marcio L F Balthazar
Journal:  Age (Dordr)       Date:  2016-04-23

8.  Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials.

Authors:  Eric Wooltorton
Journal:  CMAJ       Date:  2002-11-26       Impact factor: 8.262

Review 9.  Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions.

Authors:  Luis Agüera-Ortiz; Ganesh M Babulal; Marie-Andrée Bruneau; Byron Creese; Fabrizia D'Antonio; Corinne E Fischer; Jennifer R Gatchel; Zahinoor Ismail; Sanjeev Kumar; William J McGeown; Moyra E Mortby; Nicolas A Nuñez; Fabricio F de Oliveira; Arturo X Pereiro; Ramit Ravona-Springer; Hillary J Rouse; Huali Wang; Krista L Lanctôt
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.